COSMO Pharmaceuticals N.V.
Specialty pharma for gastroenterology/dermatology, offering colon treatments & manufacturing services.
COPN | SW
Overview
Corporate Details
- ISIN(s):
- NL0011832936
- LEI:
- 724500OX0EBQRYTVV639
- Country:
- Netherlands
- Address:
- Sir Rogerson's Quay Riverside II, Dublin 2 Dublin
- Website:
- https://www.cosmopharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
COSMO Pharmaceuticals N.V. is a specialty pharmaceutical company focused on developing and commercializing products for gastroenterology, dermatology, and healthtech. The company's therapeutic focus is on the oral and endoscopic treatment of colon diseases, including bowel diseases and colorectal cancer prevention, utilizing its proprietary MMX® technology. In addition to its own pipeline, Cosmo provides manufacturing services to other pharmaceutical companies. These services cover the production of solid, semi-solid, and liquid oral medicines and include process assessment, technology transfer, stability testing, market release, and regulatory documentation support.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-07-28 02:00 |
Cosmo und 3SBio geben Unterzeichnung einer Lizenzvereinbarung für Winlevi® in C…
|
German | 14.8 KB | ||
| 2022-07-26 02:00 |
Cosmo and Sun Pharma Announce Territory Expansion of License and Supply Agreeme…
|
English | 25.5 KB | ||
| 2022-07-26 02:00 |
Cosmo und Sun Pharma geben Gebietserweiterung der Lizenz- und Liefervereinbarun…
|
German | 26.7 KB | ||
| 2022-07-06 02:00 |
Invitation to Cosmo’s Half-Year 2022 Results Webcast on 28 July 2022
|
English | 10.5 KB | ||
| 2022-07-06 02:00 |
Einladung zum Webcast am 28. Juli 2022 zu den Halbjahresergebnissen 2022 von Co…
|
German | 11.1 KB | ||
| 2022-06-28 02:00 |
Cosmo announces acceptance of NDA submission of Cortiment® MMX® in Japan
|
English | 11.8 KB | ||
| 2022-06-28 02:00 |
Cosmo gibt Annahme des NDA-Antrags für Cortiment® MMX® in Japan bekannt
|
German | 12.9 KB | ||
| 2022-05-27 02:00 |
Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Annual General …
|
English | 12.2 KB | ||
| 2022-05-27 02:00 |
Aktionärinnen und Aktionäre von Cosmo stimmen allen
Tagungsordnungspunkten an d…
|
German | 13.0 KB |
Automate Your Workflow. Get a real-time feed of all COSMO Pharmaceuticals N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for COSMO Pharmaceuticals N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for COSMO Pharmaceuticals N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
